Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John G Gums

Showing results (61-70 of 100) with videos related to

Pageof 10
Sort By:
Plos One|January 24, 2013
Impact of genetic polymorphisms of SLC2A2, SLC2A5, and KHK on metabolic phenotypes in hypertensive individualsMyPhuong T Le, Maximilian T Lobmeyer, Marcus Campbell, et al.
Plos One|September 19, 2019
Hypertensive APOL1 risk allele carriers demonstrate greater blood pressure reduction with angiotensin receptor blockade compared to low risk carriersPatrick N Cunningham, Zhiying Wang, Megan L Grove, et al.
Journal of the American Heart Association|February 26, 2018
Genome-Wide Association Approach Identified Novel Genetic Predictors of Heart Rate Response to β-BlockersMohamed H Shahin, Daniela J Conrado, Daniel Gonzalez, et al.
American Journal of Hypertension|July 27, 2013
Night blood pressure responses to atenolol and hydrochlorothiazide in black and white patients with essential hypertensionArlene B Chapman, George Cotsonis, Vishal Parekh, et al.
Metabolic Syndrome and Related Disorders|February 10, 2015
Association of branched and aromatic amino acids levels with metabolic syndrome and impaired fasting glucose in hypertensive patientsLiming Weng, Eoin Quinlivan, Yan Gong, et al.
American Journal of Hypertension|February 13, 2019
Plasma Renin Activity Is a Predictive Biomarker of Blood Pressure Response in European but not in African Americans With Uncomplicated HypertensionMai Mehanna, Zhiying Wang, Yan Gong, et al.
American Journal of Hypertension|January 1, 2020
Response to: Heterogeneous Treatment Response by Race Cannot Be Claimed in the Absence of EvidenceMai Mehanna, Zhiying Wang, Yan Gong, et al.
Pharmacogenetics and Genomics|December 4, 2010
Polymorphisms in genes coding for GRK2 and GRK5 and response differences in antihypertensive-treated patientsMaximilian T Lobmeyer, Liewei Wang, Issam Zineh, et al.
Circulation. Cardiovascular Genetics|October 23, 2012
Hypertension susceptibility loci and blood pressure response to antihypertensives: results from the pharmacogenomic evaluation of antihypertensive responses studyYan Gong, Caitrin W McDonough, Zhiying Wang, et al.
Pharmacotherapy|October 15, 2013
PROX1 gene variant is associated with fasting glucose change after antihypertensive treatmentYan Gong, Caitrin W McDonough, Amber L Beitelshees, et al.
Pageof 10

Showing results (61-70 of 100) with videos related to

Sort By:
Pageof 10
Plos One|January 24, 2013
Impact of genetic polymorphisms of SLC2A2, SLC2A5, and KHK on metabolic phenotypes in hypertensive individualsMyPhuong T Le, Maximilian T Lobmeyer, Marcus Campbell, et al.
Plos One|September 19, 2019
Hypertensive APOL1 risk allele carriers demonstrate greater blood pressure reduction with angiotensin receptor blockade compared to low risk carriersPatrick N Cunningham, Zhiying Wang, Megan L Grove, et al.
Journal of the American Heart Association|February 26, 2018
Genome-Wide Association Approach Identified Novel Genetic Predictors of Heart Rate Response to β-BlockersMohamed H Shahin, Daniela J Conrado, Daniel Gonzalez, et al.
American Journal of Hypertension|July 27, 2013
Night blood pressure responses to atenolol and hydrochlorothiazide in black and white patients with essential hypertensionArlene B Chapman, George Cotsonis, Vishal Parekh, et al.
Metabolic Syndrome and Related Disorders|February 10, 2015
Association of branched and aromatic amino acids levels with metabolic syndrome and impaired fasting glucose in hypertensive patientsLiming Weng, Eoin Quinlivan, Yan Gong, et al.
American Journal of Hypertension|February 13, 2019
Plasma Renin Activity Is a Predictive Biomarker of Blood Pressure Response in European but not in African Americans With Uncomplicated HypertensionMai Mehanna, Zhiying Wang, Yan Gong, et al.
American Journal of Hypertension|January 1, 2020
Response to: Heterogeneous Treatment Response by Race Cannot Be Claimed in the Absence of EvidenceMai Mehanna, Zhiying Wang, Yan Gong, et al.
Pharmacogenetics and Genomics|December 4, 2010
Polymorphisms in genes coding for GRK2 and GRK5 and response differences in antihypertensive-treated patientsMaximilian T Lobmeyer, Liewei Wang, Issam Zineh, et al.
Circulation. Cardiovascular Genetics|October 23, 2012
Hypertension susceptibility loci and blood pressure response to antihypertensives: results from the pharmacogenomic evaluation of antihypertensive responses studyYan Gong, Caitrin W McDonough, Zhiying Wang, et al.
Pharmacotherapy|October 15, 2013
PROX1 gene variant is associated with fasting glucose change after antihypertensive treatmentYan Gong, Caitrin W McDonough, Amber L Beitelshees, et al.
Pageof 10